Christopher Friese

Professor Christopher R. Friese is applying his expertise to address challenges in the field of cancer care delivery. As the Elizabeth Tone Hosmer Professor of Nursing at the University of Michigan, he is deeply committed to advancing health services research and improving the quality of cancer care. Dr. Friese's academic journey began with a Bachelor of Science in Nursing from the University of Pennsylvania in 1997, followed by a Ph.D. from the same institution in 2005. His post-doctoral fellowship at the Dana-Farber Cancer Institute and Harvard University further honed his skills and knowledge in cancer research. Dr. Friese's research interests are diverse, encompassing health services research, quality of cancer care delivery, basic and translational cancer research, and public policy and social science. His work is characterized by a strong focus on measuring and enhancing the quality of cancer care, which has led to over 100 peer-reviewed publications. His contributions to the field have been recognized with numerous awards, underscoring his impact and dedication. In addition to his research, Dr. Friese is actively involved in several professional organizations. He is a respected member of the American Society of Clinical Oncology, where he collaborates with other experts to advance cancer care practices. His role on the National Cancer Advisory Board allows him to influence national cancer policy and research priorities. Furthermore, as a member of the Oncology Nursing Society, Dr. Friese contributes to the development of nursing practices that improve patient outcomes. Dr. Friese's work is not only limited to academia and research; he is also passionate about translating his findings into practical applications that benefit patients and healthcare systems. His interdisciplinary approach bridges the gap between research and practice, ensuring that his work has a tangible impact on cancer care delivery. Through his dedication to improving cancer care, Dr. Friese continues to inspire and lead efforts in the field. His commitment to excellence and innovation makes him a pivotal figure in the ongoing quest to enhance the quality of life for cancer patients and their families.